| |
| |
SPOT ON
|
| |
Pharmaceutical industry-funded research - potential for manipulation
|
| |
| |
NEW ON THE MARKET
|
| |
Nothing new - indacaterol (ONBREZ) for COPD
|
| |
| |
THERAPY FROM A CRITICAL VIEWPOINT
|
| |
Doubts over data on oseltamivir (TAMIFLU)
|
| |
| |
a-t READER'S QUESTIONS AND COMMENTS
|
| |
Coenzyme Q10: during statin treatment required?
|
 |
Dramatic rise in prices of influenza vaccines
|
| |
| |
IN BRIEF
|
| |
Ginkgo biloba (TEBONIN, generics) without effect on cognitive decline
|
| |
| |
CURRENT ADR NETWORK REPORT
|
| |
Allergic vasculitis due to tolperisone (e.g. MYDOCALM)
|
| |
| |
SIDE EFFECTS
|
| |
Chitosan (e.g. FORMOLINE L112) interactions
Breast cancer due to finasteride (PROSCAR, generics)
|
| |
| |
e a-t IN THE INTERNET
|
| |
Baclofen (LIORESAL) in alcohol dependence?
|
| |